UiPath price target raised to $25 from $23 at Macquarie

Macquarie raised the firm’s price target on UiPath to $25 from $23 and keeps an Outperform rating on the shares. The company reported solid Q3 results and the cost restructuring and realignment under its NorthStar selling program “are bearing fruit for both growth and margin,” the analyst tells investors in a research note. The firm cites UiPath’s much greater cash flow generation and margin expansion for the target raise.